Question explored with the scientific record
Is long term paracetamol effective for arthritis knee pain
The short version: paracetamol offers a tiny, clinically meaningless benefit for knee arthritis pain, and the evidence for long-term use is essentially absent.
The best evidence on paracetamol for osteoarthritis comes from a 2015 systematic review in the BMJ [1]. It pooled data from randomized placebo-controlled trials and found that paracetamol produced a pain reduction so small it was clinically insignificant. The effect size was 0.21, which means it barely beat placebo. For context, NSAIDs like ibuprofen or meloxicam produce a pain reduction about twice as large, around 10 mm on a 100 mm scale versus paracetamol's 4.7 mm [5]. The review also found that paracetamol increased the risk of abnormal liver function tests [1]. A 2011 n-of-1 trial comparing celecoxib to sustained-release paracetamol found that most patients could not tell the difference between the two, but celecoxib performed slightly better overall [6]. A 2021 trial found that a bioavailable turmeric extract was equivalent to paracetamol for WOMAC pain and function scores after six weeks, and had fewer adverse events [4]. That means a spice extract matched the drug.
The evidence for long-term use is almost nonexistent. The trials that exist run for weeks, not months or years. The 2015 BMJ review is the highest-quality source, and it found no evidence that paracetamol changes the course of the disease or provides sustained benefit [1]. The 2011 study on ibuprofen/paracetamol combinations found modest short-term benefits but also a significant drop in hemoglobin in the combination group, suggesting hidden bleeding [2]. The 2018 narrative review on NSAIDs explicitly states that NSAIDs are clearly superior to paracetamol after four weeks [5]. So the drug does not work well, and we have no idea what happens if you take it every day for a year.
| Comparison | Pain reduction (on 100 mm VAS) | Clinical significance |
|---|---|---|
| Paracetamol vs placebo | 4.7 mm [5] | Clinically insignificant |
| NSAIDs vs placebo | 10.2 mm [5] | Modest, clinically noticeable |
| Turmeric extract vs paracetamol | Equivalent [4] | Same effect, fewer side effects |
The mechanism question matters here. Paracetamol is a weak COX inhibitor with no anti-inflammatory effect. It does not address the underlying pathology of osteoarthritis, which involves mechanical wear, low-grade inflammation, and cartilage degradation. Taking it long term does nothing to slow the disease. Meanwhile, the liver toxicity risk is real, especially at doses above 3 grams per day, and the risk of gastrointestinal bleeding, though lower than with NSAIDs, is not zero. A 2011 commentary even argued that paracetamol's apparent effect in trials may be partly due to its use as a rescue medication, inflating the placebo response [3]. The drug may be doing less than the trials claim.
My call: paracetamol is not worth taking long term for knee arthritis. The benefit is too small to feel, the long-term safety data does not exist, and safer, more effective options exist, including physical therapy, NSAIDs used carefully, and even turmeric extract. Confidence: high.
Sources used 6
-
Efficacy and safety of paracetamol for spinal pain and osteoarthritis: systematic review and meta-analysis of randomised placebo controlled trials
This systematic review and meta-analysis evaluates the efficacy and safety of paracetamol for managing spinal pain and osteoarthritis, revealing that paracetamol is ineffective for low back pain and offers only a small, clinically insignificant benefit for osteoarthritis, while …
DOI: 10.1136/bmj.h1225 -
A randomised controlled trial of ibuprofen, paracetamol or a combination tablet of ibuprofen/paracetamol in community-derived people with knee pain
This study compares the efficacy and safety of single versus combination non-prescription oral analgesics in community-derived individuals aged 40 years and older with chronic knee pain, finding that ibuprofen/paracetamol combinations provide modest short-term benefits but may a…
DOI: 10.1136/ard.2011.154047 -
Paracetamol and the Placebo Effect in Osteoarthritis Trials: A Missing Link?
This paper argues that paracetamol, used as rescue medication in nearly all placebo-controlled osteoarthritis trials, may be a missing link contributing to the large placebo response by providing active symptom relief that mimics true placebo effects.
DOI: 10.1155/2011/696791 -
Bioavailable turmeric extract for knee osteoarthritis: a randomized, non-inferiority trial versus paracetamol
In a randomized non-iniority trial, bioavailable turmeric extract was as effective as paracetamol for WOMAC scores in knee osteoarthritis over 6 weeks, reduced TNF-alpha more, had fewer adverse events, and showed no significant CRP difference.
DOI: 10.1186/s13063-021-05053-7 -
A sound approach to choosing nonsteroidal anti-inflammatory drugs for osteoarthritis
This narrative review argues that NSAIDs are central to osteoarthritis pain management and that meloxicam offers proven efficacy, favorable gastrointestinal and cardiovascular safety, and should be chosen after individualized assessment of comorbid risks.
DOI: 10.14412/1996-7012-2018-4-47-53 -
Celecoxib compared with sustained-release paracetamol for osteoarthritis: a series of n-of-1 trials
This study evaluates the efficacy of celecoxib compared to sustained-release paracetamol for treating osteoarthritis through a series of n-of-1 trials, revealing that while celecoxib generally performed better, most patients could not distinguish between the two medications in t…
DOI: 10.1093/rheumatology/kel195